Total synthesis and anti-tubulin activity of epi-C3 analogues of cryptophycin-24

Journal of Medicinal Chemistry

Volumn 47, Issue 14, 2004, Pages 3697-3699

  Buck, Suzanne B ^a   Huff, Jacquelyn K ^a   Himes, Richard H ^a   Georg, Gunda I ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARENASTATIN A; CRYPTOPHYCIN DERIVATIVE; EPI C3 1,3 CHLOROBENZYLCRYPTOPHYCIN 24; EPI C3 CRYPTOPHYCIN 24; STYRENE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SYNTHESIS; EPOXIDATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROTUBULE ASSEMBLY; MULTIDRUG RESISTANCE;

ANTINEOPLASTIC AGENTS; BIOPOLYMERS; CELL LINE, TUMOR; DEPSIPEPTIDES; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; PEPTIDES, CYCLIC; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; STYRENES; TUBULIN;

EID: 3042594461     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm030555f     Document Type: Article

References (22)

1. Eggen, M.; Georg, G. I. The Cryptophycins: Their Synthesis and Anticancer Activity. Med. Res. Rev. 2002, 22, 85-101 and references therein.
2. Barrow, R. A.; Hemscheidt, T.; Liang, J.; Paik, S.; Moore, R. E.; Tius, M. A. Total Synthesis of Cryptophycins. Revision of the Structures of Cryptophycin A and C. J. Am. Chem. Soc. 1995, 117, 2479-2490.
3. Smith, C. D.; Zhang, X.; Mooberry, S. L.; Patterson, G. M. L.; Moore, R. E. Cryptophycin: A New Antimicrotubule Agent Active against Drug-Resistant Cells. Cancer Res. 1994, 54, 3779-3784.
4. Kobayashi, M.; Aoki, S.; Ohyabu, N.; Kuroso, M.; Wang, W.; Kitigawa, I. Arenastatin A, a Potent Cytotoxic Depsipeptide from the Okinawa Marine Sponge Dysidea Arenaria. Tetrahedron Lett. 1994, 35, 7969-7972.
5. Kerksiek, K.; Mejillano, M.; Schwartz, R. E.; Georg, G. I.; Himes, R. The Interaction of Cryptophycin 1 with Tubulin and Microtubules. FEBS Lett. 1995, 377, 59-61.
6. Smith, C. D.; Zhang, X. Mechanism of Action of Cryptophycin. J. Biol. Chem. 1996, 271, 6192-6198.
7. Bai, R.; Schwartz, R. E.; Kepler, J. A.; Pettit, G. R.; Hamel, E. Characterization of the Interaction of Cryptophycin 1 with Tubulin: Binding in the Vinca Domain, Competitive Inhibition of Dolastatin 10 Binding, and an Unusual Aggregation Reaction. Cancer Res. 1996, 56, 4398-4406.
8. Panda, D.; Ananthnarayan, V.; Larson, G.; Shih, C.; Jordan, M. A.; Wilson, L. Interaction of Antitumor Compound Cryptophycin-52 with Tubulin. Biochemistry 2000, 39, 14121-14127.
9. Panda, D.; Himes, R. H.; Moore, R. E.; Wilson, L.; Jordan, M. A. Mechanism of Action of the Unusually Potent Microtubule Inhibitor Cryptophycin 1. Biochemistry 1997, 36, 12948-12953.
10. Panda, D.; DeLuca, K.; Williams, D.; Jordan, M. A.; Wilson, L. Antiproliferative Mechanism of Action of Cryptophycin-52: Kinetic Stabilization of Microtubule Dynamics of High-Affinity Binding to Microtubule Ends. Proc. Natl. Acad. Sci. U.S.A. 1988, 95, 9313-9318.
11. Watts, N. R.; Cheng, N.; West, W.; Steven, A. C.; Sackett, D. L. The Cryptophycin-Tubulin Ring Structure Indicates Two Points of Curvature in the Tubulin Dimer. Biochemistry 2002, 41, 12662-12669.
12. Barbier, P.; Gregoire, C.; Devred, F.; Sarrazin, M.; Peyrot, V. In Vitro Effect of Cryptophycin 52 on Microtubule Assembly and Tubulin: Molecular Modeling of the Mechanism of Action of a New Antimitotic Drug. Biochemistry 2001, 40, 13510-13519.
13. Mooberry, S. L.; Busquets, L.; Tien, G. Induction of Apoptosis by Cryptophycin 1, a New Antimicrotubule Agent. Int. J. Cancer 1997, 73, 440-448.
14. Lu, K.; Dempsey, J.; Schultz, R. M.; Shih, C.; Teicher, B. A. Cryptophycin-Induced Hyperphosphorylation of Bcl-2, Cell Cycle Arrest and Growth Inhibition in Human H460 NSCLC Cells. Cancer Chemother. Pharmacol. 2001, 47, 170-178.
15. Mooberry, S. L.; Taoka, C. R.; Busquets, L. Cryptophycin 1 Binds to Tubulin at a Site Distinct from the Colchicine Binding Site and at a Site That May Overlap the Vinca Binding Site. Cancer Lett. 1996, 107, 53-57.
16. Morita, K.; Koiso, Y.; Hashimoto, Y.; Kobayashi, M.; Wang, W.; Ohyabu, N.; Iwasaki, S. Interaction of Arenastatin A with Porcine Brain Tubulin. Biol. Pharm. Bull. 1997, 20, 171-174.
17. Shih, C.; Al-Awar, R. S.; Fray, A. H.; Martinelli, M. J.; Moher, E. D.; Norman, B. H.; Patel, V. F.; Schultz, R. M.; Toth, J. E.; Varie, D. L.; Corbett, T. H.; Moore, R. E. Synthesis and Structure-Activity Relationship Studies of Cryptophycins: A Novel Class of Potent Antimitotic Antitumor Depsipeptides. In Anticancer Agents; Ojima, I., Vite, G. D., Altmann, K.-H., Eds.; American Chemical Society: Washington, DC, 2001; pp 171-189.
18. Eggen, M.; Mossman, C. J.; Buck, S. B.; Nair, S. K.; Bhat, L.; Ali, S. M.; Reiff, E. A.; Boge, T. C.; Georg, G. I. Total Synthesis of Cryptophycin-24 (Arenastatin A) Amenable to Structural Modifications in the C16 Side Chain. J. Org. Chem. 2000, 65, 7792-7799 and references therein.
19. Mori, K. Synthesis of Optically Active Forms of Ipsenol, the Pheromone of IPS Bark Beetles. Tetrahedron 1976, 32, 1101-1106.
20. Adam, W.; Bialas, J.; Hadjiarapoglou, L. A. Convenient Preparation of Acetone Solutions of Dimethyldioxirane. Chem. Ber. 1991, 124, 2377.
21. Patel, V. F.; Andis, S. L.; Kennedy, J. H.; Ray, J. E.; Schultz, R. M. Novel Cryptophycin Antitumor Agents: Synthesis and Cytotoxicity of Fragment "B" Analogues. J. Med. Chem. 1999, 42, 2588-2603.
22. Buck, S. B.; Huff, J. K.; Himes, R. H.; Georg, G. I. Total Synthesis and Anti-Tubulin Activity of C10 Analogues of Cryptophycin-24. J. Med. Chem. 2004, 47, 696-702 and references therein.